In summary, we have demonstrated that the novel IPI inhibitor M3258 is comparable to Btz in its anti-leukemia activity and that IPIs and Btz induce death of KMT2A::AFF1 expressing ALL cells through proteotoxic stress pathways. This evidence concerns the gene CASC3 and acute lymphoblastic leukemia.